Surgeons Have Major Influence on CPM Acceptance
| By HospiMedica International staff writers Posted on 05 Oct 2017 | 

Image: Research shows that surgeons’ opinion sways patient acceptance of contralateral breast removal (Photo courtesy of Fotolia).
			
			Attending surgeons exert influence on the likelihood of receipt of contralateral prophylactic mastectomy (CPM) after a breast cancer diagnosis.
Researchers at University of Michigan (U-M; Ann Arbor, USA), Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY, USA), and other institutions conducted a population-based survey to identify 7,810 women with stages 0 to II breast cancer treated in 2013 to 2015. The women were identified via the Surveillance, Epidemiology, and End Results (SEER) registries of the state of Georgia and Los Angeles County (CA, USA). Surveys were sent to all women approximately two months after surgery, as well as to the 488 attending surgeons identified by the patients.
In all, 5,080 women and 377 surgeons responded to the survey. The mean age of responding women was 61.9 years; 28% had an increased risk of second primary cancer, and 16% received CPM. Half of surgeons practiced for more than 20 years, and 30% treated more than 50 new patients with breast cancer annually. The results showed that the odds of a patient receiving CPM increased almost threefold if she saw a surgeon with a practice approach above that of a surgeon with the mean CPM rate.
Survey results revealed that 25% of the surgeon influence was explained by attending attitudes about initial recommendations for surgery and responses to patient requests for CPM. The estimated rate of CPM was 34% for surgeons who least favored initial breast conservation and were least reluctant to perform CPM, compared to 4% for surgeons who most favored initial breast conservation and were most reluctant to perform CPM. The study was published on September 13, 2017, in JAMA Surgery.
“Surgeons have huge influence on treatment, and with that comes ultimate responsibility to get it right with patients,” said senior author Professor Steven Katz, MD, MPH, of U-M. “Even for a procedure that is very patient-driven, we see that surgeons account for a lot of the variability in the community and those surgeon attitudes really matter in terms of whether a patient does or does not get CPM.”
CPM is defined as the removal of a healthy breast in a patient undergoing mastectomy for ipsilateral cancer. The rate of CPM is steadily increasing, with a number of possible reasons cited; these include increased patient awareness of the genetic and familial risks, use of magnetic resonance imaging (MRI), improved reconstructive techniques, and patient choice. The procedure conveys peace of mind to patients and is generally met with high patient satisfaction.
Related Links:
University of Michigan
Memorial Sloan-Kettering Cancer Center
		
			
			
		
        		        
		        Researchers at University of Michigan (U-M; Ann Arbor, USA), Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY, USA), and other institutions conducted a population-based survey to identify 7,810 women with stages 0 to II breast cancer treated in 2013 to 2015. The women were identified via the Surveillance, Epidemiology, and End Results (SEER) registries of the state of Georgia and Los Angeles County (CA, USA). Surveys were sent to all women approximately two months after surgery, as well as to the 488 attending surgeons identified by the patients.
In all, 5,080 women and 377 surgeons responded to the survey. The mean age of responding women was 61.9 years; 28% had an increased risk of second primary cancer, and 16% received CPM. Half of surgeons practiced for more than 20 years, and 30% treated more than 50 new patients with breast cancer annually. The results showed that the odds of a patient receiving CPM increased almost threefold if she saw a surgeon with a practice approach above that of a surgeon with the mean CPM rate.
Survey results revealed that 25% of the surgeon influence was explained by attending attitudes about initial recommendations for surgery and responses to patient requests for CPM. The estimated rate of CPM was 34% for surgeons who least favored initial breast conservation and were least reluctant to perform CPM, compared to 4% for surgeons who most favored initial breast conservation and were most reluctant to perform CPM. The study was published on September 13, 2017, in JAMA Surgery.
“Surgeons have huge influence on treatment, and with that comes ultimate responsibility to get it right with patients,” said senior author Professor Steven Katz, MD, MPH, of U-M. “Even for a procedure that is very patient-driven, we see that surgeons account for a lot of the variability in the community and those surgeon attitudes really matter in terms of whether a patient does or does not get CPM.”
CPM is defined as the removal of a healthy breast in a patient undergoing mastectomy for ipsilateral cancer. The rate of CPM is steadily increasing, with a number of possible reasons cited; these include increased patient awareness of the genetic and familial risks, use of magnetic resonance imaging (MRI), improved reconstructive techniques, and patient choice. The procedure conveys peace of mind to patients and is generally met with high patient satisfaction.
Related Links:
University of Michigan
Memorial Sloan-Kettering Cancer Center
Latest Surgical Techniques News
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
- Micro Imaging Device Paired with Endoscope Spots Cancers at Earlier Stage
Channels
Critical Care
view channel 
                    Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
Monitoring blood flow in the brain is crucial for diagnosing and treating neurological conditions such as stroke, traumatic brain injury (TBI), and vascular dementia. However, current imaging methods like... Read more 
                    AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
For decades, doctors have relied on standardized scoring systems to assess patients with the most common type of heart attack—non-ST-elevation acute coronary syndrome (NSTE-ACS). The GRACE score, used... Read morePatient Care
view channel 
                    Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more 
                    VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more 
                    Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more 
                    First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel 
                    Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel 
                    Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more 
                    B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more 
                    CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more 
                    















 
								

 
								
 
								 
                     
                     
                    